Decomposing ‘refrigerants,’ a potent greenhouse gas, using industrial waste
23 Jul
Science & Technology

Decomposing ‘refrigerants,’ a potent greenhouse gas, using industrial waste

Posted by author-avatar
0
Technology tamfitronics Industrial waste red mud raw material (left) and pelletized red mud catalyst (right). Credit: Korea Institute Of Energy Research A research team has developed a technology to decompose refrigerants, a greenhouse gas 1,300 times more potent than carbon dioxide, using challenging-to-handle industrial waste. ...
Continue reading
Intermountain Health First to Use New 3D Technology for Patients Undergoing Complex Cancer Surgery
23 Jul
Science & Technology

Intermountain Health First to Use New 3D Technology for Patients Undergoing Complex Cancer Surgery

Posted by author-avatar
0
Technology tamfitronics With new medical innovation, Intermountain Health first in nation to use new 3D technology to improve treatment for patients undergoing complex cancer surgery.Using a new 3D computer model of the surgical area, Intermountain Health is the first health system in the nation to use new technology for robotic rectal cancer surgery with more precision and effectiveness for patients.The new technology, called Iris, converts preoperative MRI images into a 3D model that shows the anatomy and location of the tumor in relation to other organs and structures to enhance the accuracy and effectiveness of the surgical procedure.Tae Kim, MD, a colorectal surgeon at Intermountain LDS Hospital in Salt Lake City, was the first physician to use the Iris technology for a rectal robotic surgery.“The benefit of this technology is like having a 3D map...
Continue reading
Click editing enables programmable genome writing using DNA polymerases and HUH endonucleases
23 Jul
Science & Technology

Click editing enables programmable genome writing using DNA polymerases and HUH endonucleases

Posted by author-avatar
0
Technology tamfitronics Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578229–236 (2020).Article CAS PubMed PubMed Central Google Scholar Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38824–844 (2020).Article CAS PubMed Google Scholar ...
Continue reading
Editor’s pick: Indapta Therapeutics
23 Jul
Science & Technology

Editor’s pick: Indapta Therapeutics

Posted by author-avatar
0
Technology tamfitronics Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Indapta Therapeutics is using a subset of natural killer cells found in healthy donors to supercharge monoclonal antibodies to fight cancer and autoimmune disease. Natural killer (NK) cells, the cytotoxic effector cells of the innate immune system, are attractive candidates for immunotherapy because of their ability to generally recognize and kill stressed cells, such as tumor cells and virus-infected cells. However, some NK cells are better killers than others, depending on their specific repertoire of inhibitory and activating receptors that bind to respective ligands on target cells. Indapta Therapeutics aims to harness the power of a subset of...
Continue reading
Load more posts
Loading...